nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—CYP2D6—Carteolol—glaucoma	0.074	0.104	CbGbCtD
Enzalutamide—CYP2D6—Betaxolol—glaucoma	0.05	0.0705	CbGbCtD
Enzalutamide—CYP2C19—Methazolamide—glaucoma	0.0499	0.0703	CbGbCtD
Enzalutamide—CYP2C9—Diclofenamide—glaucoma	0.0482	0.0679	CbGbCtD
Enzalutamide—CYP2C9—Dorzolamide—glaucoma	0.0465	0.0655	CbGbCtD
Enzalutamide—CYP3A5—Clonidine—glaucoma	0.0447	0.063	CbGbCtD
Enzalutamide—CYP2C19—Timolol—glaucoma	0.0424	0.0598	CbGbCtD
Enzalutamide—CYP2C9—Methazolamide—glaucoma	0.0415	0.0584	CbGbCtD
Enzalutamide—CYP2D6—Methazolamide—glaucoma	0.0379	0.0534	CbGbCtD
Enzalutamide—CYP3A4—Pilocarpine—glaucoma	0.0357	0.0503	CbGbCtD
Enzalutamide—ABCB1—Timolol—glaucoma	0.0342	0.0482	CbGbCtD
Enzalutamide—CYP2D6—Timolol—glaucoma	0.0322	0.0454	CbGbCtD
Enzalutamide—ABCB1—Clonidine—glaucoma	0.0291	0.041	CbGbCtD
Enzalutamide—CYP3A4—Brinzolamide—glaucoma	0.028	0.0395	CbGbCtD
Enzalutamide—CYP2D6—Clonidine—glaucoma	0.0274	0.0386	CbGbCtD
Enzalutamide—CYP3A4—Dorzolamide—glaucoma	0.027	0.0381	CbGbCtD
Enzalutamide—CYP3A4—Methazolamide—glaucoma	0.0241	0.034	CbGbCtD
Enzalutamide—CYP3A4—Acetazolamide—glaucoma	0.0193	0.0272	CbGbCtD
Enzalutamide—CYP3A4—Clonidine—glaucoma	0.0174	0.0246	CbGbCtD
Enzalutamide—Musculoskeletal discomfort—Latanoprost—glaucoma	0.000869	0.00331	CcSEcCtD
Enzalutamide—Sinusitis—Pilocarpine—glaucoma	0.000869	0.00331	CcSEcCtD
Enzalutamide—Rhinitis—Brinzolamide—glaucoma	0.000867	0.0033	CcSEcCtD
Enzalutamide—Urinary tract disorder—Travoprost—glaucoma	0.000865	0.00329	CcSEcCtD
Enzalutamide—Connective tissue disorder—Travoprost—glaucoma	0.000861	0.00328	CcSEcCtD
Enzalutamide—Hypoaesthesia—Brinzolamide—glaucoma	0.000861	0.00328	CcSEcCtD
Enzalutamide—Urethral disorder—Travoprost—glaucoma	0.000859	0.00327	CcSEcCtD
Enzalutamide—Pharyngitis—Brinzolamide—glaucoma	0.000858	0.00327	CcSEcCtD
Enzalutamide—Nasopharyngitis—Clonidine—glaucoma	0.000858	0.00327	CcSEcCtD
Enzalutamide—Urinary tract disorder—Brinzolamide—glaucoma	0.000854	0.00325	CcSEcCtD
Enzalutamide—Oedema peripheral—Brinzolamide—glaucoma	0.000852	0.00324	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Methazolamide—glaucoma	0.000851	0.00324	CcSEcCtD
Enzalutamide—Connective tissue disorder—Brinzolamide—glaucoma	0.00085	0.00324	CcSEcCtD
Enzalutamide—Fatigue—Methazolamide—glaucoma	0.000849	0.00323	CcSEcCtD
Enzalutamide—Urethral disorder—Brinzolamide—glaucoma	0.000848	0.00323	CcSEcCtD
Enzalutamide—Asthenia—Metipranolol—glaucoma	0.000843	0.00321	CcSEcCtD
Enzalutamide—Angiopathy—Brimonidine—glaucoma	0.000836	0.00318	CcSEcCtD
Enzalutamide—Rhinitis—Pilocarpine—glaucoma	0.000833	0.00317	CcSEcCtD
Enzalutamide—Hypoaesthesia—Pilocarpine—glaucoma	0.000827	0.00315	CcSEcCtD
Enzalutamide—Pharyngitis—Pilocarpine—glaucoma	0.000825	0.00314	CcSEcCtD
Enzalutamide—Oedema peripheral—Pilocarpine—glaucoma	0.000819	0.00312	CcSEcCtD
Enzalutamide—Vertigo—Bimatoprost—glaucoma	0.000814	0.0031	CcSEcCtD
Enzalutamide—Mental disorder—Brimonidine—glaucoma	0.000807	0.00307	CcSEcCtD
Enzalutamide—Angiopathy—Travoprost—glaucoma	0.000795	0.00303	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00079	0.00301	CcSEcCtD
Enzalutamide—Angiopathy—Brinzolamide—glaucoma	0.000785	0.00299	CcSEcCtD
Enzalutamide—Hypertension—Bimatoprost—glaucoma	0.000782	0.00298	CcSEcCtD
Enzalutamide—Asthenia—Carteolol—glaucoma	0.000781	0.00297	CcSEcCtD
Enzalutamide—Dizziness—Metipranolol—glaucoma	0.000777	0.00296	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Clonidine—glaucoma	0.000771	0.00293	CcSEcCtD
Enzalutamide—Anxiety—Bimatoprost—glaucoma	0.000768	0.00292	CcSEcCtD
Enzalutamide—Asthenia—Diclofenamide—glaucoma	0.000768	0.00292	CcSEcCtD
Enzalutamide—Mental disorder—Travoprost—glaucoma	0.000767	0.00292	CcSEcCtD
Enzalutamide—Pollakiuria—Clonidine—glaucoma	0.000766	0.00292	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000766	0.00291	CcSEcCtD
Enzalutamide—Mental disorder—Brinzolamide—glaucoma	0.000758	0.00288	CcSEcCtD
Enzalutamide—Infection—Apraclonidine—glaucoma	0.000757	0.00288	CcSEcCtD
Enzalutamide—Pruritus—Diclofenamide—glaucoma	0.000757	0.00288	CcSEcCtD
Enzalutamide—Leukopenia—Acetazolamide—glaucoma	0.000748	0.00285	CcSEcCtD
Enzalutamide—Nervous system disorder—Apraclonidine—glaucoma	0.000748	0.00285	CcSEcCtD
Enzalutamide—Nasopharyngitis—Betaxolol—glaucoma	0.000747	0.00284	CcSEcCtD
Enzalutamide—Back pain—Dorzolamide—glaucoma	0.000741	0.00282	CcSEcCtD
Enzalutamide—Skin disorder—Apraclonidine—glaucoma	0.00074	0.00282	CcSEcCtD
Enzalutamide—Asthenia—Levobunolol—glaucoma	0.000738	0.00281	CcSEcCtD
Enzalutamide—Back pain—Travoprost—glaucoma	0.000738	0.00281	CcSEcCtD
Enzalutamide—Headache—Metipranolol—glaucoma	0.000736	0.0028	CcSEcCtD
Enzalutamide—Infection—Bimatoprost—glaucoma	0.000734	0.00279	CcSEcCtD
Enzalutamide—Back pain—Brinzolamide—glaucoma	0.000728	0.00277	CcSEcCtD
Enzalutamide—Pruritus—Levobunolol—glaucoma	0.000728	0.00277	CcSEcCtD
Enzalutamide—Amnesia—Timolol—glaucoma	0.000726	0.00277	CcSEcCtD
Enzalutamide—Nervous system disorder—Bimatoprost—glaucoma	0.000725	0.00276	CcSEcCtD
Enzalutamide—Convulsion—Acetazolamide—glaucoma	0.000724	0.00276	CcSEcCtD
Enzalutamide—Dizziness—Carteolol—glaucoma	0.00072	0.00274	CcSEcCtD
Enzalutamide—Skin disorder—Bimatoprost—glaucoma	0.000718	0.00273	CcSEcCtD
Enzalutamide—Diarrhoea—Carbachol—glaucoma	0.000715	0.00272	CcSEcCtD
Enzalutamide—Dizziness—Diclofenamide—glaucoma	0.000708	0.00269	CcSEcCtD
Enzalutamide—Asthenia—Methazolamide—glaucoma	0.000707	0.00269	CcSEcCtD
Enzalutamide—Diarrhoea—Levobunolol—glaucoma	0.000704	0.00268	CcSEcCtD
Enzalutamide—Back pain—Pilocarpine—glaucoma	0.0007	0.00266	CcSEcCtD
Enzalutamide—Epistaxis—Clonidine—glaucoma	0.000698	0.00265	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000695	0.00264	CcSEcCtD
Enzalutamide—Bronchitis—Betaxolol—glaucoma	0.000694	0.00264	CcSEcCtD
Enzalutamide—Hypertension—Brimonidine—glaucoma	0.000692	0.00264	CcSEcCtD
Enzalutamide—Dizziness—Carbachol—glaucoma	0.000691	0.00263	CcSEcCtD
Enzalutamide—Insomnia—Apraclonidine—glaucoma	0.00069	0.00262	CcSEcCtD
Enzalutamide—Vertigo—Dorzolamide—glaucoma	0.000688	0.00262	CcSEcCtD
Enzalutamide—Vertigo—Travoprost—glaucoma	0.000685	0.00261	CcSEcCtD
Enzalutamide—Paraesthesia—Apraclonidine—glaucoma	0.000685	0.00261	CcSEcCtD
Enzalutamide—Arthralgia—Brimonidine—glaucoma	0.000683	0.0026	CcSEcCtD
Enzalutamide—Headache—Carteolol—glaucoma	0.000682	0.00259	CcSEcCtD
Enzalutamide—Anxiety—Brimonidine—glaucoma	0.00068	0.00259	CcSEcCtD
Enzalutamide—Dizziness—Levobunolol—glaucoma	0.00068	0.00259	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000678	0.00258	CcSEcCtD
Enzalutamide—Vertigo—Brinzolamide—glaucoma	0.000676	0.00257	CcSEcCtD
Enzalutamide—Pruritus—Latanoprost—glaucoma	0.000675	0.00257	CcSEcCtD
Enzalutamide—Diarrhoea—Methazolamide—glaucoma	0.000674	0.00257	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Betaxolol—glaucoma	0.000671	0.00255	CcSEcCtD
Enzalutamide—Headache—Diclofenamide—glaucoma	0.00067	0.00255	CcSEcCtD
Enzalutamide—Insomnia—Bimatoprost—glaucoma	0.000669	0.00254	CcSEcCtD
Enzalutamide—Thrombocytopenia—Acetazolamide—glaucoma	0.000668	0.00254	CcSEcCtD
Enzalutamide—Rhinitis—Clonidine—glaucoma	0.000666	0.00253	CcSEcCtD
Enzalutamide—Hypertension—Dorzolamide—glaucoma	0.000661	0.00252	CcSEcCtD
Enzalutamide—Hypoaesthesia—Clonidine—glaucoma	0.000661	0.00251	CcSEcCtD
Enzalutamide—Hypertension—Travoprost—glaucoma	0.000658	0.00251	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000658	0.00251	CcSEcCtD
Enzalutamide—Fatigue—Apraclonidine—glaucoma	0.000657	0.0025	CcSEcCtD
Enzalutamide—Headache—Carbachol—glaucoma	0.000654	0.00249	CcSEcCtD
Enzalutamide—Arthralgia—Dorzolamide—glaucoma	0.000652	0.00248	CcSEcCtD
Enzalutamide—Infection—Brimonidine—glaucoma	0.00065	0.00247	CcSEcCtD
Enzalutamide—Hypertension—Brinzolamide—glaucoma	0.00065	0.00247	CcSEcCtD
Enzalutamide—Anxiety—Dorzolamide—glaucoma	0.00065	0.00247	CcSEcCtD
Enzalutamide—Arthralgia—Travoprost—glaucoma	0.000649	0.00247	CcSEcCtD
Enzalutamide—Leukopenia—Pilocarpine—glaucoma	0.000648	0.00247	CcSEcCtD
Enzalutamide—Pneumonia—Betaxolol—glaucoma	0.000648	0.00246	CcSEcCtD
Enzalutamide—Anxiety—Travoprost—glaucoma	0.000647	0.00246	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000645	0.00245	CcSEcCtD
Enzalutamide—Headache—Levobunolol—glaucoma	0.000644	0.00245	CcSEcCtD
Enzalutamide—Infestation NOS—Betaxolol—glaucoma	0.000644	0.00245	CcSEcCtD
Enzalutamide—Infestation—Betaxolol—glaucoma	0.000644	0.00245	CcSEcCtD
Enzalutamide—Nervous system disorder—Brimonidine—glaucoma	0.000642	0.00244	CcSEcCtD
Enzalutamide—Arthralgia—Brinzolamide—glaucoma	0.000641	0.00244	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000638	0.00243	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000637	0.00242	CcSEcCtD
Enzalutamide—Skin disorder—Brimonidine—glaucoma	0.000636	0.00242	CcSEcCtD
Enzalutamide—Dizziness—Latanoprost—glaucoma	0.000631	0.0024	CcSEcCtD
Enzalutamide—Hypertension—Pilocarpine—glaucoma	0.000625	0.00238	CcSEcCtD
Enzalutamide—Infection—Travoprost—glaucoma	0.000618	0.00235	CcSEcCtD
Enzalutamide—Headache—Methazolamide—glaucoma	0.000617	0.00235	CcSEcCtD
Enzalutamide—Arthralgia—Pilocarpine—glaucoma	0.000616	0.00235	CcSEcCtD
Enzalutamide—Anxiety—Pilocarpine—glaucoma	0.000614	0.00234	CcSEcCtD
Enzalutamide—Paraesthesia—Acetazolamide—glaucoma	0.000612	0.00233	CcSEcCtD
Enzalutamide—Infection—Brinzolamide—glaucoma	0.00061	0.00232	CcSEcCtD
Enzalutamide—Nervous system disorder—Travoprost—glaucoma	0.00061	0.00232	CcSEcCtD
Enzalutamide—Nasopharyngitis—Timolol—glaucoma	0.00061	0.00232	CcSEcCtD
Enzalutamide—Epistaxis—Betaxolol—glaucoma	0.000607	0.00231	CcSEcCtD
Enzalutamide—Skin disorder—Travoprost—glaucoma	0.000605	0.0023	CcSEcCtD
Enzalutamide—Sinusitis—Betaxolol—glaucoma	0.000604	0.0023	CcSEcCtD
Enzalutamide—Nervous system disorder—Brinzolamide—glaucoma	0.000603	0.00229	CcSEcCtD
Enzalutamide—Angiopathy—Clonidine—glaucoma	0.000602	0.00229	CcSEcCtD
Enzalutamide—Headache—Latanoprost—glaucoma	0.000597	0.00227	CcSEcCtD
Enzalutamide—Skin disorder—Brinzolamide—glaucoma	0.000597	0.00227	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000596	0.00227	CcSEcCtD
Enzalutamide—Insomnia—Brimonidine—glaucoma	0.000592	0.00225	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000589	0.00224	CcSEcCtD
Enzalutamide—Fatigue—Acetazolamide—glaucoma	0.000588	0.00224	CcSEcCtD
Enzalutamide—Paraesthesia—Brimonidine—glaucoma	0.000588	0.00224	CcSEcCtD
Enzalutamide—Infection—Pilocarpine—glaucoma	0.000587	0.00223	CcSEcCtD
Enzalutamide—Mental disorder—Clonidine—glaucoma	0.000582	0.00221	CcSEcCtD
Enzalutamide—Rhinitis—Betaxolol—glaucoma	0.000579	0.00221	CcSEcCtD
Enzalutamide—Thrombocytopenia—Pilocarpine—glaucoma	0.000578	0.0022	CcSEcCtD
Enzalutamide—Hypoaesthesia—Betaxolol—glaucoma	0.000575	0.00219	CcSEcCtD
Enzalutamide—Pharyngitis—Betaxolol—glaucoma	0.000574	0.00218	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000569	0.00217	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Travoprost—glaucoma	0.000567	0.00216	CcSEcCtD
Enzalutamide—Insomnia—Dorzolamide—glaucoma	0.000565	0.00215	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Brimonidine—glaucoma	0.000565	0.00215	CcSEcCtD
Enzalutamide—Fatigue—Brimonidine—glaucoma	0.000564	0.00215	CcSEcCtD
Enzalutamide—Paraesthesia—Dorzolamide—glaucoma	0.000561	0.00214	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00056	0.00213	CcSEcCtD
Enzalutamide—Insomnia—Brinzolamide—glaucoma	0.000556	0.00212	CcSEcCtD
Enzalutamide—Paraesthesia—Brinzolamide—glaucoma	0.000552	0.0021	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Timolol—glaucoma	0.000548	0.00209	CcSEcCtD
Enzalutamide—Asthenia—Apraclonidine—glaucoma	0.000547	0.00208	CcSEcCtD
Enzalutamide—Pruritus—Apraclonidine—glaucoma	0.000539	0.00205	CcSEcCtD
Enzalutamide—Fatigue—Dorzolamide—glaucoma	0.000539	0.00205	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000538	0.00205	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Travoprost—glaucoma	0.000537	0.00205	CcSEcCtD
Enzalutamide—Fatigue—Travoprost—glaucoma	0.000537	0.00204	CcSEcCtD
Enzalutamide—Insomnia—Pilocarpine—glaucoma	0.000534	0.00203	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000531	0.00202	CcSEcCtD
Enzalutamide—Paraesthesia—Pilocarpine—glaucoma	0.00053	0.00202	CcSEcCtD
Enzalutamide—Asthenia—Bimatoprost—glaucoma	0.00053	0.00202	CcSEcCtD
Enzalutamide—Fatigue—Brinzolamide—glaucoma	0.00053	0.00202	CcSEcCtD
Enzalutamide—Angiopathy—Betaxolol—glaucoma	0.000524	0.002	CcSEcCtD
Enzalutamide—Pruritus—Bimatoprost—glaucoma	0.000523	0.00199	CcSEcCtD
Enzalutamide—Diarrhoea—Apraclonidine—glaucoma	0.000522	0.00199	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00051	0.00194	CcSEcCtD
Enzalutamide—Mental disorder—Betaxolol—glaucoma	0.000506	0.00193	CcSEcCtD
Enzalutamide—Dizziness—Apraclonidine—glaucoma	0.000504	0.00192	CcSEcCtD
Enzalutamide—Epistaxis—Timolol—glaucoma	0.000496	0.00189	CcSEcCtD
Enzalutamide—Sinusitis—Timolol—glaucoma	0.000493	0.00188	CcSEcCtD
Enzalutamide—Arthralgia—Clonidine—glaucoma	0.000492	0.00187	CcSEcCtD
Enzalutamide—Anxiety—Clonidine—glaucoma	0.00049	0.00187	CcSEcCtD
Enzalutamide—Asthenia—Acetazolamide—glaucoma	0.000489	0.00186	CcSEcCtD
Enzalutamide—Dizziness—Bimatoprost—glaucoma	0.000489	0.00186	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000489	0.00186	CcSEcCtD
Enzalutamide—Headache—Apraclonidine—glaucoma	0.000478	0.00182	CcSEcCtD
Enzalutamide—Rhinitis—Timolol—glaucoma	0.000473	0.0018	CcSEcCtD
Enzalutamide—Asthenia—Brimonidine—glaucoma	0.00047	0.00179	CcSEcCtD
Enzalutamide—Infection—Clonidine—glaucoma	0.000469	0.00178	CcSEcCtD
Enzalutamide—Diarrhoea—Acetazolamide—glaucoma	0.000467	0.00178	CcSEcCtD
Enzalutamide—Oedema peripheral—Timolol—glaucoma	0.000465	0.00177	CcSEcCtD
Enzalutamide—Connective tissue disorder—Timolol—glaucoma	0.000464	0.00177	CcSEcCtD
Enzalutamide—Pruritus—Brimonidine—glaucoma	0.000463	0.00176	CcSEcCtD
Enzalutamide—Headache—Bimatoprost—glaucoma	0.000463	0.00176	CcSEcCtD
Enzalutamide—Nervous system disorder—Clonidine—glaucoma	0.000463	0.00176	CcSEcCtD
Enzalutamide—Thrombocytopenia—Clonidine—glaucoma	0.000462	0.00176	CcSEcCtD
Enzalutamide—Skin disorder—Clonidine—glaucoma	0.000458	0.00174	CcSEcCtD
Enzalutamide—Vertigo—Betaxolol—glaucoma	0.000452	0.00172	CcSEcCtD
Enzalutamide—Dizziness—Acetazolamide—glaucoma	0.000451	0.00172	CcSEcCtD
Enzalutamide—Asthenia—Dorzolamide—glaucoma	0.000448	0.00171	CcSEcCtD
Enzalutamide—Asthenia—Travoprost—glaucoma	0.000447	0.0017	CcSEcCtD
Enzalutamide—Pruritus—Dorzolamide—glaucoma	0.000442	0.00168	CcSEcCtD
Enzalutamide—Asthenia—Brinzolamide—glaucoma	0.000441	0.00168	CcSEcCtD
Enzalutamide—Pruritus—Travoprost—glaucoma	0.00044	0.00168	CcSEcCtD
Enzalutamide—Pruritus—Brinzolamide—glaucoma	0.000435	0.00165	CcSEcCtD
Enzalutamide—Dizziness—Brimonidine—glaucoma	0.000433	0.00165	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Clonidine—glaucoma	0.00043	0.00164	CcSEcCtD
Enzalutamide—Angiopathy—Timolol—glaucoma	0.000428	0.00163	CcSEcCtD
Enzalutamide—Arthralgia—Betaxolol—glaucoma	0.000428	0.00163	CcSEcCtD
Enzalutamide—Diarrhoea—Dorzolamide—glaucoma	0.000428	0.00163	CcSEcCtD
Enzalutamide—Headache—Acetazolamide—glaucoma	0.000427	0.00163	CcSEcCtD
Enzalutamide—Anxiety—Betaxolol—glaucoma	0.000427	0.00162	CcSEcCtD
Enzalutamide—Insomnia—Clonidine—glaucoma	0.000427	0.00162	CcSEcCtD
Enzalutamide—Diarrhoea—Travoprost—glaucoma	0.000426	0.00162	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000425	0.00162	CcSEcCtD
Enzalutamide—Asthenia—Pilocarpine—glaucoma	0.000424	0.00161	CcSEcCtD
Enzalutamide—Paraesthesia—Clonidine—glaucoma	0.000424	0.00161	CcSEcCtD
Enzalutamide—Diarrhoea—Brinzolamide—glaucoma	0.00042	0.0016	CcSEcCtD
Enzalutamide—Pruritus—Pilocarpine—glaucoma	0.000418	0.00159	CcSEcCtD
Enzalutamide—Mental disorder—Timolol—glaucoma	0.000414	0.00157	CcSEcCtD
Enzalutamide—Dizziness—Dorzolamide—glaucoma	0.000413	0.00157	CcSEcCtD
Enzalutamide—Dizziness—Travoprost—glaucoma	0.000412	0.00157	CcSEcCtD
Enzalutamide—Headache—Brimonidine—glaucoma	0.00041	0.00156	CcSEcCtD
Enzalutamide—Infection—Betaxolol—glaucoma	0.000408	0.00155	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Clonidine—glaucoma	0.000407	0.00155	CcSEcCtD
Enzalutamide—Fatigue—Clonidine—glaucoma	0.000407	0.00155	CcSEcCtD
Enzalutamide—Dizziness—Brinzolamide—glaucoma	0.000406	0.00155	CcSEcCtD
Enzalutamide—Diarrhoea—Pilocarpine—glaucoma	0.000404	0.00154	CcSEcCtD
Enzalutamide—Nervous system disorder—Betaxolol—glaucoma	0.000403	0.00153	CcSEcCtD
Enzalutamide—Thrombocytopenia—Betaxolol—glaucoma	0.000402	0.00153	CcSEcCtD
Enzalutamide—Skin disorder—Betaxolol—glaucoma	0.000399	0.00152	CcSEcCtD
Enzalutamide—Headache—Dorzolamide—glaucoma	0.000392	0.00149	CcSEcCtD
Enzalutamide—Dizziness—Pilocarpine—glaucoma	0.000391	0.00149	CcSEcCtD
Enzalutamide—Headache—Travoprost—glaucoma	0.00039	0.00148	CcSEcCtD
Enzalutamide—Headache—Brinzolamide—glaucoma	0.000385	0.00147	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000374	0.00142	CcSEcCtD
Enzalutamide—Insomnia—Betaxolol—glaucoma	0.000371	0.00141	CcSEcCtD
Enzalutamide—Headache—Pilocarpine—glaucoma	0.00037	0.00141	CcSEcCtD
Enzalutamide—Vertigo—Timolol—glaucoma	0.000369	0.00141	CcSEcCtD
Enzalutamide—Paraesthesia—Betaxolol—glaucoma	0.000369	0.0014	CcSEcCtD
Enzalutamide—Hypertension—Timolol—glaucoma	0.000355	0.00135	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Betaxolol—glaucoma	0.000355	0.00135	CcSEcCtD
Enzalutamide—Fatigue—Betaxolol—glaucoma	0.000354	0.00135	CcSEcCtD
Enzalutamide—Arthralgia—Timolol—glaucoma	0.00035	0.00133	CcSEcCtD
Enzalutamide—Anxiety—Timolol—glaucoma	0.000349	0.00133	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000348	0.00132	CcSEcCtD
Enzalutamide—Asthenia—Clonidine—glaucoma	0.000338	0.00129	CcSEcCtD
Enzalutamide—Pruritus—Clonidine—glaucoma	0.000334	0.00127	CcSEcCtD
Enzalutamide—Infection—Timolol—glaucoma	0.000333	0.00127	CcSEcCtD
Enzalutamide—Nervous system disorder—Timolol—glaucoma	0.000329	0.00125	CcSEcCtD
Enzalutamide—Skin disorder—Timolol—glaucoma	0.000326	0.00124	CcSEcCtD
Enzalutamide—Diarrhoea—Clonidine—glaucoma	0.000323	0.00123	CcSEcCtD
Enzalutamide—Dizziness—Clonidine—glaucoma	0.000312	0.00119	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Timolol—glaucoma	0.000306	0.00116	CcSEcCtD
Enzalutamide—Insomnia—Timolol—glaucoma	0.000303	0.00115	CcSEcCtD
Enzalutamide—Paraesthesia—Timolol—glaucoma	0.000301	0.00115	CcSEcCtD
Enzalutamide—Headache—Clonidine—glaucoma	0.000295	0.00112	CcSEcCtD
Enzalutamide—Asthenia—Betaxolol—glaucoma	0.000295	0.00112	CcSEcCtD
Enzalutamide—Pruritus—Betaxolol—glaucoma	0.000291	0.00111	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Timolol—glaucoma	0.00029	0.0011	CcSEcCtD
Enzalutamide—Fatigue—Timolol—glaucoma	0.000289	0.0011	CcSEcCtD
Enzalutamide—Diarrhoea—Betaxolol—glaucoma	0.000281	0.00107	CcSEcCtD
Enzalutamide—Dizziness—Betaxolol—glaucoma	0.000272	0.00103	CcSEcCtD
Enzalutamide—Headache—Betaxolol—glaucoma	0.000257	0.000979	CcSEcCtD
Enzalutamide—Asthenia—Timolol—glaucoma	0.000241	0.000916	CcSEcCtD
Enzalutamide—Pruritus—Timolol—glaucoma	0.000237	0.000903	CcSEcCtD
Enzalutamide—Diarrhoea—Timolol—glaucoma	0.00023	0.000874	CcSEcCtD
Enzalutamide—Dizziness—Timolol—glaucoma	0.000222	0.000844	CcSEcCtD
Enzalutamide—Headache—Timolol—glaucoma	0.00021	0.0008	CcSEcCtD
Enzalutamide—ABCB1—Allograft Rejection—FAS—glaucoma	6.56e-05	0.00236	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—CYP1B1—glaucoma	6.51e-05	0.00234	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—C3—glaucoma	6.47e-05	0.00233	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	6.42e-05	0.00231	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—FN1—glaucoma	6.41e-05	0.00231	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GSTT1—glaucoma	6.31e-05	0.00227	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	6.11e-05	0.0022	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	6.09e-05	0.00219	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.05e-05	0.00218	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CA5A—glaucoma	5.86e-05	0.00211	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NARFL—glaucoma	5.86e-05	0.00211	CbGpPWpGaD
Enzalutamide—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	5.81e-05	0.00209	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GSTT1—glaucoma	5.81e-05	0.00209	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GSTT1—glaucoma	5.76e-05	0.00207	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CA5A—glaucoma	5.72e-05	0.00206	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NARFL—glaucoma	5.72e-05	0.00206	CbGpPWpGaD
Enzalutamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	5.72e-05	0.00206	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.7e-05	0.00205	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—CYP1B1—glaucoma	5.64e-05	0.00203	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	5.56e-05	0.002	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	5.56e-05	0.002	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	5.54e-05	0.00199	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	5.39e-05	0.00194	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—GSTM1—glaucoma	5.32e-05	0.00192	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.3e-05	0.00191	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.27e-05	0.0019	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	5.25e-05	0.00189	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.24e-05	0.00189	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—GSTM1—glaucoma	5.2e-05	0.00187	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	5.13e-05	0.00185	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	5.03e-05	0.00181	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.99e-05	0.0018	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	4.96e-05	0.00179	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CA5A—glaucoma	4.96e-05	0.00179	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NARFL—glaucoma	4.96e-05	0.00179	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NARFL—glaucoma	4.93e-05	0.00177	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CA5A—glaucoma	4.93e-05	0.00177	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	4.75e-05	0.00171	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.73e-05	0.0017	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.7e-05	0.00169	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—CDKN2B—glaucoma	4.64e-05	0.00167	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	4.63e-05	0.00167	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.62e-05	0.00167	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	4.59e-05	0.00165	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	4.56e-05	0.00164	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	4.52e-05	0.00163	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—TNF—glaucoma	4.51e-05	0.00162	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—GSTM1—glaucoma	4.51e-05	0.00162	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	4.44e-05	0.0016	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NARFL—glaucoma	4.43e-05	0.00159	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CA5A—glaucoma	4.43e-05	0.00159	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CA5A—glaucoma	4.32e-05	0.00156	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NARFL—glaucoma	4.32e-05	0.00156	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	4.32e-05	0.00155	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.29e-05	0.00154	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.13e-05	0.00149	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	4.09e-05	0.00147	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—NR3C1—glaucoma	4.07e-05	0.00147	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CA5A—glaucoma	4.07e-05	0.00147	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NARFL—glaucoma	4.07e-05	0.00147	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CA5A—glaucoma	4.04e-05	0.00145	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NARFL—glaucoma	4.04e-05	0.00145	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.03e-05	0.00145	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.02e-05	0.00145	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	3.97e-05	0.00143	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—TNF—glaucoma	3.96e-05	0.00143	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.93e-05	0.00142	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.81e-05	0.00137	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.8e-05	0.00137	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.78e-05	0.00136	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.75e-05	0.00135	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.7e-05	0.00133	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—VEGFA—glaucoma	3.67e-05	0.00132	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TNF—glaucoma	3.67e-05	0.00132	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.67e-05	0.00132	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.65e-05	0.00131	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.62e-05	0.0013	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	3.59e-05	0.00129	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.53e-05	0.00127	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	3.5e-05	0.00126	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.37e-05	0.00121	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.25e-05	0.00117	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.24e-05	0.00117	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—glaucoma	3.23e-05	0.00116	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.03e-05	0.00109	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.98e-05	0.00107	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.97e-05	0.00107	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.95e-05	0.00106	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—TNF—glaucoma	2.91e-05	0.00105	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CA1—glaucoma	2.86e-05	0.00103	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	2.84e-05	0.00102	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CA1—glaucoma	2.8e-05	0.00101	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TNF—glaucoma	2.78e-05	0.001	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB2—glaucoma	2.78e-05	0.001	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CTSA—glaucoma	2.77e-05	0.000997	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.77e-05	0.000997	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CTSA—glaucoma	2.71e-05	0.000975	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NARFL—glaucoma	2.66e-05	0.000958	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA5A—glaucoma	2.66e-05	0.000958	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CA2—glaucoma	2.62e-05	0.000942	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.59e-05	0.000931	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CA2—glaucoma	2.56e-05	0.000921	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CA1—glaucoma	2.42e-05	0.000872	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.42e-05	0.000871	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CA1—glaucoma	2.41e-05	0.000867	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.39e-05	0.000859	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CTSA—glaucoma	2.34e-05	0.000844	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CTSA—glaucoma	2.33e-05	0.00084	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—CDKN2B—glaucoma	2.23e-05	0.000804	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CA2—glaucoma	2.21e-05	0.000797	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CA2—glaucoma	2.2e-05	0.000793	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.16e-05	0.000779	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.16e-05	0.000779	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CA1—glaucoma	2.16e-05	0.000778	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.15e-05	0.000775	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.15e-05	0.000775	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CA1—glaucoma	2.11e-05	0.00076	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SOD1—glaucoma	2.11e-05	0.000759	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CTSA—glaucoma	2.09e-05	0.000754	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CTSA—glaucoma	2.04e-05	0.000736	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.04e-05	0.000733	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CA1—glaucoma	1.99e-05	0.000716	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CA2—glaucoma	1.98e-05	0.000712	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CA1—glaucoma	1.97e-05	0.00071	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NR3C1—glaucoma	1.96e-05	0.000706	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.93e-05	0.000696	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.93e-05	0.000696	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CA2—glaucoma	1.93e-05	0.000695	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.93e-05	0.000694	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CTSA—glaucoma	1.93e-05	0.000693	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CTSA—glaucoma	1.91e-05	0.000687	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TXN—glaucoma	1.84e-05	0.000664	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CA2—glaucoma	1.82e-05	0.000655	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CA2—glaucoma	1.8e-05	0.000649	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TXN—glaucoma	1.8e-05	0.000649	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.76e-05	0.000634	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.76e-05	0.000634	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.63e-05	0.000586	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MMP1—glaucoma	1.61e-05	0.000579	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.6e-05	0.000577	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TXN—glaucoma	1.56e-05	0.000562	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TXN—glaucoma	1.55e-05	0.000559	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—CAV1—glaucoma	1.54e-05	0.000555	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—FN1—glaucoma	1.47e-05	0.000528	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTT1—glaucoma	1.43e-05	0.000515	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.42e-05	0.000513	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.42e-05	0.00051	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.41e-05	0.000508	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.4e-05	0.000505	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTT1—glaucoma	1.4e-05	0.000503	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TXN—glaucoma	1.39e-05	0.000501	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.37e-05	0.000495	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TXN—glaucoma	1.36e-05	0.000489	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA1—glaucoma	1.3e-05	0.000468	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TXN—glaucoma	1.28e-05	0.000461	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.27e-05	0.000458	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TXN—glaucoma	1.27e-05	0.000457	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.26e-05	0.000453	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CTSA—glaucoma	1.26e-05	0.000453	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.21e-05	0.000436	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTT1—glaucoma	1.21e-05	0.000436	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTT1—glaucoma	1.2e-05	0.000433	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA2—glaucoma	1.19e-05	0.000428	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS3—glaucoma	1.16e-05	0.000419	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.16e-05	0.000417	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.15e-05	0.000413	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1B1—glaucoma	1.14e-05	0.00041	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCA1—glaucoma	1.14e-05	0.00041	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1B1—glaucoma	1.11e-05	0.000401	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCA1—glaucoma	1.11e-05	0.000401	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTT1—glaucoma	1.08e-05	0.000389	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTT1—glaucoma	1.05e-05	0.000379	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTT1—glaucoma	9.93e-06	0.000358	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTT1—glaucoma	9.85e-06	0.000355	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.75e-06	0.000351	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.7e-06	0.000349	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCA1—glaucoma	9.64e-06	0.000347	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1B1—glaucoma	9.64e-06	0.000347	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1B1—glaucoma	9.58e-06	0.000345	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCA1—glaucoma	9.58e-06	0.000345	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—glaucoma	9.1e-06	0.000328	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—glaucoma	8.9e-06	0.00032	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.71e-06	0.000314	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1B1—glaucoma	8.6e-06	0.00031	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCA1—glaucoma	8.6e-06	0.00031	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ABCA1—glaucoma	8.4e-06	0.000302	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1B1—glaucoma	8.4e-06	0.000302	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—glaucoma	8.39e-06	0.000302	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TXN—glaucoma	8.37e-06	0.000302	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—glaucoma	8.04e-06	0.00029	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.94e-06	0.000286	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1B1—glaucoma	7.91e-06	0.000285	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCA1—glaucoma	7.91e-06	0.000285	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—glaucoma	7.86e-06	0.000283	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCA1—glaucoma	7.85e-06	0.000282	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1B1—glaucoma	7.85e-06	0.000282	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—glaucoma	7.71e-06	0.000277	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—glaucoma	7.66e-06	0.000276	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOE—glaucoma	7.49e-06	0.00027	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CAV1—glaucoma	7.42e-06	0.000267	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOE—glaucoma	7.32e-06	0.000264	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CAV1—glaucoma	7.25e-06	0.000261	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—glaucoma	6.88e-06	0.000248	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—glaucoma	6.81e-06	0.000245	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—glaucoma	6.77e-06	0.000244	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—glaucoma	6.71e-06	0.000242	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—glaucoma	6.49e-06	0.000234	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—glaucoma	6.34e-06	0.000228	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOE—glaucoma	6.34e-06	0.000228	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—glaucoma	6.33e-06	0.000228	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOE—glaucoma	6.3e-06	0.000227	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAV1—glaucoma	6.28e-06	0.000226	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—glaucoma	6.27e-06	0.000226	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAV1—glaucoma	6.25e-06	0.000225	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—glaucoma	6.08e-06	0.000219	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—glaucoma	5.93e-06	0.000214	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOE—glaucoma	5.66e-06	0.000204	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—glaucoma	5.61e-06	0.000202	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAV1—glaucoma	5.61e-06	0.000202	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—glaucoma	5.59e-06	0.000201	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—glaucoma	5.54e-06	0.0002	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOE—glaucoma	5.52e-06	0.000199	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—glaucoma	5.48e-06	0.000197	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAV1—glaucoma	5.47e-06	0.000197	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOE—glaucoma	5.21e-06	0.000187	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCA1—glaucoma	5.17e-06	0.000186	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1B1—glaucoma	5.17e-06	0.000186	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOE—glaucoma	5.16e-06	0.000186	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAV1—glaucoma	5.16e-06	0.000186	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—glaucoma	5.13e-06	0.000185	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAV1—glaucoma	5.11e-06	0.000184	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—glaucoma	5.02e-06	0.000181	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—glaucoma	4.75e-06	0.000171	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—glaucoma	4.72e-06	0.00017	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—glaucoma	4.34e-06	0.000156	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—glaucoma	4.32e-06	0.000156	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—glaucoma	4.24e-06	0.000153	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—glaucoma	4.14e-06	0.000149	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—glaucoma	4.14e-06	0.000149	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—glaucoma	3.9e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—glaucoma	3.88e-06	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—glaucoma	3.87e-06	0.000139	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—glaucoma	3.78e-06	0.000136	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—glaucoma	3.66e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—glaucoma	3.57e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—glaucoma	3.54e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOE—glaucoma	3.4e-06	0.000123	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAV1—glaucoma	3.37e-06	0.000121	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—glaucoma	2.55e-06	9.18e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—glaucoma	2.33e-06	8.4e-05	CbGpPWpGaD
